Virtual Microscope Images at your Fingertips
Researchers and educators are now able to access their entire library of virtual microscope images with just a tap of the finger on the OlyVIA Mobile iPad App.
Free to download from the iTunes App Store, the app is designed for images captured with the Olympus VS120 virtual slide scanning system. Images shared via the Olympus Net Image ServerSQL v.2.7 software can now be conveniently accessed from anywhere in the world using the iPad. In addition to VS120 images, any images captured in or converted to the .vsi file format, including images from cellSens software, are uploadable for remote viewing on an iPad.
With a click, tap or finger pinch, users can verify, select, pan, zoom and observe their virtual images at different magnifications. The OlyVIA Mobile App makes the most of both the familiar user-friendliness and portability of the iPad, combined with the excellent image quality of the Olympus VS120 system to provide an insightful user experience. Users who download the free app will also have access to a library of high quality virtual slide images that can be used for demonstration or educational purposes.
The modular Olympus VS120 virtual slide system creates high-resolution digital images of complete microscope specimens that can be stored on a server for simultaneous remote viewing, at a range of magnifications. The system is optimised to provide outstanding brightfield and fluorescence performance, combined with precise colour rendition and scanning. The VS120 earned three First Place awards at the biennial International Scanner Contest (ISC) in 2012, claiming victory in the important categories of Colour and Precision, Fluorescence 20x and Fluorescence 40x. The system also won two awards at the inaugural contest in 2010.
For more information on the Olympus OlyVIA Mobile iPad app, please visit www.olympus-europa.com/microscopy, or download OlyVIA Mobile from the App Store on iTunes.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance